Mr Trevor St Baker AO, a member of the Board of Directors of NOVONIX Ltd and major shareholder of the company through the St Baker Energy Innovation Fund, has been honoured today by the University of Queensland with the award of Doctor of Engineering, honoris causa. The award was bestowed by the Senate of The…

Battery scientist Jeff Dahn extends Tesla contract, forges new role with NOVONIX – January 2021

The Driven reports on noted North American researcher Prof. Jeff Dahn joining NOVONIX as Chief Scientific Advisor, effective July 1, 2021. For more information, click here:

U.S. Department of Energy grants NOVONIX A$7.1M for tech development – January 2021

Quoted in The Market Herald, Dr. Burns says ‘This award demonstrates the commitment by the government to support the establishment of a domestic supply of high-performance battery materials. It also highlights the expertise, progress, partners and technology we have assembled at PUREgraphite. Click here for more information

NOVONIX Announces Strategic Alliance with Harper International on Specialized Furnace Technology – December 2020

‘NOVONIX’s CEO, Dr. Chris Burns, said ‘Harper’s track record and experience made them the ideal company to work with on innovative thermal processing systems. NOVONIX’s unique thermal processing technology is central to our ability to produce high performance materials at globally competitive costs. This combination of technologies, experience and capabilities creates a powerful alliance to…

CEO Dr Chris Burns Interview with Proactive – October 2020

Burns says the group is commercializing their synthetic graphite product, and is under contract to be supplied to Samsung. Burns says the group is looking forward to supporting the ‘huge’ expected growth of electric vehicle and energy storage space

Read: Novonix is fully funded for growth and development – July 2020

Upon completion of NOVONIX’s $63M AUD capital raise to clean pay off all debt and fund growth, the Market Herald reports on NOVONIX’s plan for growth and planned investments in R&D.